Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
8th grade Avg
|
|
New words:
added, analytical, anticancer, Bay, belonging, billion, biomedical, bivatuzumab, borne, CanAg, confirmed, diagnosed, EITF, electronically, exploit, exploiting, expressly, external, extra, FAS, fermentation, filer, FIN, fixed, gave, half, herewith, IDEC, inclusion, insufficient, judgment, leg, lifetime, linker, living, MA, Marsden, Mary, McCann, merged, Northeastern, occupy, outlicense, Park, path, people, point, preexisting, procure, prominent, prospective, regain, regained, rejoined, relicense, relicensing, relinquish, resemble, residing, Rituxan, Rituximab, rolling, Rule, run, semisynthetic, sending, Springfield, Sr, subheadingCommon, succeed, Task, taxane, tender, trastuzumab, unconditional, unconjugated, unexercised, unidentified, usage, website, Weston, written
Removed:
Academy, Advisory, amortization, amortized, authority, began, Biology, Boston, California, Certificate, colon, conform, Consent, consisting, credited, evaluated, Evan, extending, finder, fund, Gerard, Harvard, Head, implemented, inadequate, mammalian, managed, member, noted, programmed, proliferation, regimen, reliance, residual, retroactive, Richard, Schlossman, standard, subleased, traditionally, venture
Filing tables
Filing exhibits
IMGN similar filings
Filing view
External links
QuickLinks -- Click here to rapidly navigate through this document
EXHIBIT 24
Consent of Independent Auditors
We hereby consent to the incorporation by reference in the Registration Statements on Forms S-3 (File Nos. 333-02441, 333-07661, 333-15819, 333-22153, 333-31795, 333-48042, 333-48385, 333-57234 and 333-100123) and Form S-8 (File Nos. 333-41534, 333-73544, 333-47543, 333-53292, 333-75372 and 333-75374) of ImmunoGen, Inc. of our report dated August 14, 2001 relating to the financial statements, which appears in this Form 10-K.
/s/ Pricewaterhouse Coopers LLP
Boston, Massachusetts
September 24, 2003
Consent of Independent Auditors